Document Detail


Effect of prenatal glucocorticoid treatment on size at birth among infants born at term gestation.
MedLine Citation:
PMID:  19587690     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To determine whether prenatal treatment with a single course of glucocorticoids (GCs) affects size at birth among full-term infants independent of fetal size before GC administration or exposure to preterm labor (PTL).
STUDY DESIGN: In all, 105 full-term infants were recruited into three study groups (30 GC treated; 60 controls matched for gestational age (GA) at birth and sex; and 15 PTL controls without GC exposure). Size of the infants was estimated before treatment using two-dimensional (2D) ultrasound and by direct measurement at birth.
RESULTS: Length, weight and head circumference at birth were smaller among GC-treated infants compared with matched controls (P's<0.01), although fetal size did not differ before treatment (P's>0.2). Exposure to PTL did not account for this effect.
CONCLUSIONS: Prenatal treatment with a single course of GCs was associated with a reduction in size at birth among infants born at term gestation. This effect cannot be explained by differences in fetal size before treatment or exposure to PTL.
Authors:
E P Davis; F Waffarn; C Uy; C J Hobel; L M Glynn; C A Sandman
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2009-07-09
Journal Detail:
Title:  Journal of perinatology : official journal of the California Perinatal Association     Volume:  29     ISSN:  1476-5543     ISO Abbreviation:  J Perinatol     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-10-28     Completed Date:  2010-02-01     Revised Date:  2012-04-25    
Medline Journal Info:
Nlm Unique ID:  8501884     Medline TA:  J Perinatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  731-7     Citation Subset:  IM    
Affiliation:
Department of Psychiatry and Human Behavior, University of California, Irvine, Orange, CA 92677, USA. edavis@uci.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anti-Inflammatory Agents / administration & dosage,  adverse effects*
Betamethasone / administration & dosage,  adverse effects*
Birth Weight / drug effects*
Female
Fetal Development / drug effects
Humans
Infant, Newborn
Male
Obstetric Labor, Premature / drug therapy
Pregnancy
Respiratory Distress Syndrome, Newborn / prevention & control*
Ultrasonography, Prenatal
Grant Support
ID/Acronym/Agency:
HD-50662/HD/NICHD NIH HHS; NS-41298/NS/NINDS NIH HHS; R01 HD050662-02/HD/NICHD NIH HHS; R01 HD065823/HD/NICHD NIH HHS
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents; 378-44-9/Betamethasone
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Bisphenol-A and disparities in birth outcomes: a review and directions for future research.
Next Document:  Thermal Injury Causes DNA Damage and Lethality in Unheated Surrounding Cells: Active Thermal Bystand...